Dysfunctional Lens Index Serves as a Novel Surgery Decision Maker for Age-related Cataracts
1 other identifier
interventional
60
1 country
1
Brief Summary
To study the correlations among the dysfunctional lens index (DLI), Lens Opacities Classification System III (LOCS III) nuclear opalescence grading score, preoperative corrected distance visual acuity (CDVA), the objective scatter index (OSI) and Scheimpflug based average lens density in age-related cataracts. To investigate the potential of the DLI as a novel surgery decision maker via the Operating Characteristic (ROC) curve analysis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2017
CompletedFirst Submitted
Initial submission to the registry
November 6, 2017
CompletedFirst Posted
Study publicly available on registry
November 13, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2018
CompletedNovember 13, 2017
November 1, 2017
8 months
November 6, 2017
November 8, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Dysfunctional lens index
The DLI is an objective lens performance metric derived from internal higher order aberrations (HOAs), pupil size, and contrast sensitivity data
6 months
Study Arms (1)
cataract surgery
EXPERIMENTALcataract extraction and intraocular implantation
Interventions
The Dysfunctional Lens Index is obtained by a ray-tracing aberrometry
Eligibility Criteria
You may qualify if:
- patients with age-related cataracts
You may not qualify if:
- any corneal opacity, corneal dystrophies, retinal anomalies, a history of ocular surgery or laser treatment, a LOCS III grade of cortical opacity ≥ 3.0 or posterior subcapsular cataract ≥ 2.0.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Eye Hospital of Wenzhou Medical College
Wenzhou, Zhejiang, 325027, China
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director
Study Record Dates
First Submitted
November 6, 2017
First Posted
November 13, 2017
Study Start
September 1, 2017
Primary Completion
May 1, 2018
Study Completion
December 1, 2018
Last Updated
November 13, 2017
Record last verified: 2017-11
Data Sharing
- IPD Sharing
- Will not share